Case Report: A Rare Cause of Ischemic Stroke in the Intensive Care Unit: Venous Sinus Thrombosis
PDF
Cite
Share
Request
Case Report
P: 56-60
March 2022

Case Report: A Rare Cause of Ischemic Stroke in the Intensive Care Unit: Venous Sinus Thrombosis

J Turk Soc Intens Care 2022;20(1):56-60
1. İzmir Tınaztepe Üniversitesi Sağlık Hizmetleri Meslek Yüksekokulu, Anestezi Bölümü; İzmir Tınaztepe Galen Hastanesi, Anesteziyoloji ve Reanimasyon Kliniği, İzmir, Türkiye
2. Tınaztepe Galen Bayraklı Hastanesi, Anesteziyoloji ve Reanimasyon Kliniği, İzmir, Türkiye
3. Tınaztepe Galen Bayraklı Hastanesi, Radyoloji Kliniği, İzmir, Türkiye
4. İzmir Tınaztepe Galen Hastanesi, Anesteziyoloji ve Reanimasyon Kliniği, İzmir, Türkiye
5. İzmir Tınaztepe Galen Hastanesi, Radyoloji Kliniği, İzmir, Türkiye
No information available.
No information available
Received Date: 23.06.2020
Accepted Date: 16.11.2021
Publish Date: 02.03.2022
PDF
Cite
Share
Request

ABSTRACT

A 36-year-old female patient had headache and generalized tonic-clonic seizure. Due to headache, nausea, facial twitching, difficulty in swallowing, contraction of jaw, anemiadand generalized tonic convulsion the patient hadundergone cranial computed tomography (CT) and magnetic resonance (MR) venography. The results were found to be consistent with venous infarction and encephalitis in the right temporoparietal region. The patient was administered low molecular weight heparins, antiepileptic medication, acyclovir and ceftriaxone. On the second day, the patient’s tendency to sleep increased and hemiparesis developed in the left upper and lower extremities. The superior sagittal sinus is most commonly affected in venous sinus thrombosis (VST). Symptoms may vary depending on the localization of the thrombosis. Headache, increased intracranial pressure findings, epileptic seizures and focal neurological disorders are the most common clinical findings. In addition to clinical findings, CT, contrast-enhanced MR imaging and MR venography are used in the diagnosis of VST. Oral contraceptive (OCS) use in individuals with genetic risk, labor or a penetrating trauma event may induce VST. It has been shown that there may be a relationship between iron deficiency anemia and VST, especially if the hemoglobin value is below 9 g/dL, which increases the risk of VST. Kidney failure, hypothyroidism, smoking and high homocysteine level are among the other factors that are accused. Treatment of VST should be started immediately. Treatment should be directed towards the primary cause leading to anticoagulation and clinical VST. The ability of venous thrombosis to respond to anticoagulant treatment makes it important to start treatment early. We think that it is important to investigate VST with imaging methods, especially in cases where there are predisposing factors such as pregnancy and OCS use.

Keywords: Sinus vein thrombosis, stroke, intensive care

References

1
Masuhr F, Mehraein S, Einhäupl K. Cerebral venous and sinus thrombosis. J Neurol 2004;251:11-23.
2
Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011;2011:CD002005. 
3
Kamışlı Ö, Arslan D, Altınayar S, Kamışlı S, Kablan Y, Özcan C. Serebral venöz sinüs trombozu: klinik değerlendirme. Türk Serebrovasküler Hastalıklar Dergisi 2009;15:39-42.
4
Kocatürk Ö, Coşkun Ö, Öcal R, İnan LE, Özkan S. Serebral venöz trombozlu hastalarda risk faktörleri ve etiyolojik sebeplerin ve tedavi özelliklerinin retrospektif incelenmesi. ADÜ Tıp Fakültesi Dergisi 2012;13:13-8.
5
Einhäupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010;17:1229-35. 
6
Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:1158-92. 
7
Uluğ E, Özhan İ, Uluğ V, Ganiüsmen O, Binatlı AÖ, Özdamar N. Gebelik ve Serebral Venöz Tromboz: Bir Vaka Sunumu. Türk Nöroşirürji Dergisi 2008;18:56-61.
8
Filippidis A, Kapsalaki E, Patramani G, Fountas KN. Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus 2009;27:E3.
9
Kaya D, Yıldız E. Importance of gre on the diagnosis of venous sinus thrombosis. ACU Sağlık Bil Derg 2011;2:57-60.
10
Altıparmak UE, Yalnız Z, Şatana BS, Kasım R. Hiperhomosisteinemili Olguda Serebral Ven Trombozu ve Bilateral Optik Atrofi. T Oft Gaz 2008;38:269-72.
11
Hon SF, Li HL, Cheng PW. Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis. J Stroke Cerebrovasc Dis 2012;21:915.e11-5.
12
Dalgiç A, Seçer M, Ergüngör F, Okay O, Akdağ R, Ciliz D. Dural sinus thrombosis following head injury: report of two cases and review of the literature. Turk Neurosurg 2008;18:70-7.
13
Balduz M, Kapan O, Özdemir HH, Dağlı İN, Demir CF. Gebelikte hemorajik infarkt ile komplike serebral venöz tromboz. Türk Serebrovasküler Hastalıklar Dergisi 2011;17:29-31.
14
Titiz A, Öztürk Ş, Eren Y, Özbakır Ş. Clinical and etiological evaluation of sinus thrombosis. J Neurol Sci 2007;24:56-63.
15
Wilder-Smith E, Kothbauer-Margreiter I, Lämmle B, Sturzenegger M, Ozdoba C, Hauser SP. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis. J Neurol Neurosurg Psychiatry 1997;63:351-6.
16
Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2005;26:618-24. 
17
Ferro JM, Canhão P. Cerebral venous sinus thrombosis: update on diagnosis and management. Curr Cardiol Rep 2014;16:523.
18
Geisbüsch C, Richter D, Herweh C, Ringleb PA, Nagel S. Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke 2014;45:2469-71.
19
Açıkgöz B, Kalaycı M, Gül Ş, Çağavi F. Cerebral venous-sinus thrombosis. Turkiye Klinikleri J Surg Med Sci 2006;2:169-74.
20
Çelik ÇÇ, Sezer E, Özdemir ÖA, Özkan S, Erdinç OO. Serebral Venlerin de Tutulduğu Atipik Serebral Venöz Tromboz Olgusu. Türk Beyin Damar Hast Derg 2011;17:33-5.
21
Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry 2003;74:459-61.
22
Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation 2010;121:2740-6. 
23
Gulati D, Strbian D, Sundararajan S. Cerebral venous thrombosis: diagnosis and management. Stroke 2014;45:e16-8. 
24
Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-70. 
2024 ©️ Galenos Publishing House